Yaping Xu
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 5
-
- Cancer Genomics and Diagnostics 15
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Co-authors
- Yanfang Guan (9 shared papers)Lianpeng Chang (6 shared papers)Xuefeng Xia (6 shared papers)Lifeng Li (5 shared papers)Meng Zhang (1 shared paper)Yan Gong (1 shared paper)Yu Yao (1 shared paper)Yongliang Zhang (1 shared paper)
- Journals
- Frontiers in Oncology (6 papers)Nanoscale Advances (3 papers)Clinical Cancer Research (2 papers)Annals of Translational Medicine (2 papers)Organic Chemistry Frontiers (1 paper)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Yaping Xu
61 papers receiving 1.2k citations
Yaping Xu's Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 526
- Oncology 359
- Pathology and Forensic Medicine 172
- Molecular Biology 460
- Pulmonary and Respiratory Medicine 218
Countries citing papers authored by Yaping Xu
This map shows the geographic impact of Yaping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Xu more than expected).
Fields of papers citing papers by Yaping Xu
This network shows the impact of papers produced by Yaping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Xu. The network helps show where Yaping Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaping Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients Hit paper breakdown → | 2021 | 201 |
| 2 | 2020 | 96 | |
| 3 | 2020 | 50 | |
| 4 | 2020 | 49 | |
| 5 | 2022 | 48 | |
| 6 | 2021 | 46 | |
| 7 | 2021 | 45 | |
| 8 | The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma. | 2019 | 44 |
| 9 | 2019 | 36 | |
| 10 | 2018 | 32 | |
| 11 | 2020 | 31 | |
| 12 | 2017 | 31 | |
| 13 | 2015 | 30 | |
| 14 | 2005 | 29 | |
| 15 | 2019 | 27 | |
| 16 | 2020 | 21 | |
| 17 | 2014 | 21 | |
| 18 | 2021 | 20 | |
| 19 | 2021 | 19 | |
| 20 | 2023 | 17 |
About Yaping Xu
Yaping Xu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), Genetic factors in colorectal cancer (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Circular RNAs in diseases (5 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Advancements in Battery Materials (5 papers). The work is most often cited by research in Cancer Research (526 citations), Oncology (359 citations), Pathology and Forensic Medicine (172 citations), Molecular Biology (460 citations) and Pulmonary and Respiratory Medicine (218 citations). Yaping Xu has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yanfang Guan, Lianpeng Chang, Xuefeng Xia, Lifeng Li, Meng Zhang, Yan Gong, Yu Yao, Yongliang Zhang, Shuqin Jia and Kai Zhang. Their work appears in journals such as Frontiers in Oncology, Nanoscale Advances, Clinical Cancer Research, Annals of Translational Medicine and Organic Chemistry Frontiers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.